BridgeBio Oncology Therapeutics, Inc. — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by BridgeBio Oncology Therapeutics, Inc. (BBOT), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Oncology Therapeutics, Inc. has filed 4 SCHEDULE 13G/A documents with the SEC since 2023. To view all SEC filings by BridgeBio Oncology Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
425
8-A12B
8-K
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-4
S-4/A
S-8
SC 13D
SC 13G
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001104659-25-112512 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-004881 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-072172 | Jul 30, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-000396 | Apr 22, 2025 | — |